1887

Abstract

Coagulase-negative staphylococci (CoNS) have become increasingly recognized as important agents of nosocomial infection. One of the characteristics of CoNS is their resistance to multiple antimicrobial agents commonly used for the treatment of staphylococcal infections. CoNS strains ( = 745) isolated from a university teaching hospital in China between 2004 and 2009 were tested for antibiotic resistance. The antibiotics were placed into three categories based on resistance levels of the CoNS strains to these antibiotics: high resistance (resistance rate >70 %), including penicillin G, oxacillin and erythromycin; medium resistance (resistance rate between 30 and 70 %), including tetracycline, clindamycin, ciprofloxacin, trimethoprim/sulfamethoxazole and chloramphenicol; and low resistance (resistance rate <30 %), including rifampicin, ceftizoxime and gentamicin. We also found that the prevalence of strains non-susceptible to teicoplanin increased from 4.5 to 6.7 % between 2008 and 2009. A one-step vancomycin agar selection experiment and subsequent population analysis revealed potentially vancomycin-resistant subpopulations that have been selected from the teicoplanin-non-susceptible strains. Vigilant surveillance of nosocomial isolates of CoNS is needed to determine their resistance to glycopeptides.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.034066-0
2011-11-01
2019-12-05
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/11/1661.html?itemId=/content/journal/jmm/10.1099/jmm.0.034066-0&mimeType=html&fmt=ahah

References

  1. Bourgeois I., Pestel-Caron M., Lemeland J. F., Pons J. L., Caron F.. ( 2007;). Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci. . Antimicrob Agents Chemother 51:, 740–743. [CrossRef][PubMed]
    [Google Scholar]
  2. Boyce J. M.. ( 2004;). Coagulase-negative staphylococci. . In Hospital Epidemiology and Infection Control, , 3rd edn., pp. 495–516. Edited by Mayhall C. G... Philadelphia, PA:: Lippincott Williams & Wilkins;.
    [Google Scholar]
  3. Casey A. L., Lambert P. A., Elliott T. S. J.. ( 2007;). Staphylococci. . Int J Antimicrob Agents 29: (Suppl. 3), S23–S32. [CrossRef]
    [Google Scholar]
  4. Cervera C., Almela M., Martínez-Martínez J. A., Moreno A., Miró J. M.. ( 2009;). Risk factors and management of Gram-positive bacteraemia. . Int J Antimicrob Agents 34: (Suppl. 4), S26–S30. [CrossRef]
    [Google Scholar]
  5. CLSI ( 2010;). Performance Standards for Antimicrobial Susceptibility Testing, 19th Informational Supplement, M100–S19. . Wayne, PA:: Clinical and Laboratory Standards Institute;.
  6. Cremniter J., Slassi A., Quincampoix J. C., Sivadon-Tardy V., Bauer T., Porcher R., Lortat-Jacob A., Piriou P., Judet T. et al. & other authors ( 2010;). Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative staphylococci isolated from orthopedic-device-associated infections. . J Clin Microbiol 48:, 1428–1431. [CrossRef][PubMed]
    [Google Scholar]
  7. Dubois D., Leyssene D., Chacornac J. P., Kostrzewa M., Schmit P. O., Talon R., Bonnet R., Delmas J.. ( 2010;). Identification of a variety of Staphylococcus species by matrix-assisted laser desorption ionization-time of flight mass spectrometry. . J Clin Microbiol 48:, 941–945. [CrossRef][PubMed]
    [Google Scholar]
  8. Ferreira R. B., Iorio N. L., Malvar K. L., Nunes A. P., Fonseca L. S., Bastos C. C., Santos K. R.. ( 2003;). Coagulase-negative staphylococci: comparison of phenotypic and genotypic oxacillin susceptibility tests and evaluation of the agar screening test by using different concentrations of oxacillin. . J Clin Microbiol 41:, 3609–3614. [CrossRef][PubMed]
    [Google Scholar]
  9. Gazzola S., Cocconcelli P. S.. ( 2008;). Vancomycin heteroresistance and biofilm formation in Staphylococcus epidermidis from food. . Microbiology 154:, 3224–3231. [CrossRef][PubMed]
    [Google Scholar]
  10. Huebner J., Goldmann D. A.. ( 1999;). Coagulase-negative staphylococci: role as pathogens. . Annu Rev Med 50:, 223–236. [CrossRef][PubMed]
    [Google Scholar]
  11. Hung K. H., Yan J. J., Lu Y. C., Chen H. M., Wu J. J.. ( 2011;). Evaluation of discrepancies between oxacillin and cefoxitin susceptibility in coagulase-negative staphylococci. . Eur J Clin Microbiol Infect Dis 30:, 785–788. [CrossRef][PubMed]
    [Google Scholar]
  12. Kristóf K., Kocsis E., Szabó D., Kardos S., Cser V., Nagy K., Hermann P., Rozgonyi F.. ( 2011;). Significance of methicillin-teicoplanin resistant Staphylococcus haemolyticus in bloodstream infections in patients of the Semmelweis University hospitals in Hungary. . Eur J Clin Microbiol Infect Dis 30:, 691–699. [CrossRef][PubMed]
    [Google Scholar]
  13. Lorenzo-Díaz F., Delgado T., Reyes-Darias J. A., Flores C., Méndez-Alvarez S., Villar J., Sierra A., Claverie-Martín F.. ( 2004;). Characterization of the first VanB vancomycin-resistant Enterococcus faecium isolated in a Spanish hospital. . Curr Microbiol 48:, 199–203. [CrossRef][PubMed]
    [Google Scholar]
  14. Ma X. X., Sun D. D., Hu J., Wang E. H., Luo E. J.. ( 2011;). Epidemiological and molecular characterization of Staphylococcus haemolyticus strains, from a hematology ward, with decreased susceptibility to glycopeptides. . Can J Microbiol 57:, 476–484. [CrossRef][PubMed]
    [Google Scholar]
  15. Maniati M., Petinaki E., Spiliopoulou I., Kontos, Petropoulou-Mylona D., Spaliara L., Malamou-Lada H., Koutsia-Carouzou C., Maniatis A. N.. ( 2005;). Rapid increase in numbers of Staphylococcus epidermidis strains with reduced susceptibility to teicoplanin in Greece. . Int J Antimicrob Agents 25:, 346–348. [CrossRef][PubMed]
    [Google Scholar]
  16. Matsuhashi M., Song M. D., Ishino F., Wachi M., Doi M., Inoue M., Ubukata K., Yamashita N., Konno M.. ( 1986;). Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to β-lactam antibiotics in Staphylococcus aureus. . J Bacteriol 167:, 975–980.[PubMed]
    [Google Scholar]
  17. Natoli S., Fontana C., Favaro M., Bergamini A., Testore G. P., Minelli S., Bossa M. C., Casapulla M., Broglio G. et al. & other authors ( 2009;). Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options. . BMC Infect Dis 9:, 83. [CrossRef][PubMed]
    [Google Scholar]
  18. Otto M.. ( 2009;). Staphylococcus epidermidis – the ‘accidental’ pathogen. . Nat Rev Microbiol 7:, 555–567. [CrossRef][PubMed]
    [Google Scholar]
  19. Palazzo I. C., Araujo M. L., Darini A. L.. ( 2005;). First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil. . J Clin Microbiol 43:, 179–185. [CrossRef][PubMed]
    [Google Scholar]
  20. Périchon B., Courvalin P.. ( 2009;). VanA-type vancomycin-resistant Staphylococcus aureus. . Antimicrob Agents Chemother 53:, 4580–4587. [CrossRef][PubMed]
    [Google Scholar]
  21. Sieradzki K., Villari P., Tomasz A.. ( 1998;). Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. . Antimicrob Agents Chemother 42:, 100–107.[PubMed]
    [Google Scholar]
  22. Srinivasan A., Dick J. D., Perl T. M.. ( 2002;). Vancomycin resistance in staphylococci. . Clin Microbiol Rev 15:, 430–438. [CrossRef][PubMed]
    [Google Scholar]
  23. Stefani S., Varaldo P. E.. ( 2003;). Epidemiology of methicillin-resistant staphylococci in Europe. . Clin Microbiol Infect 9:, 1179–1186. [CrossRef][PubMed]
    [Google Scholar]
  24. Tacconelli E., Tumbarello M., Donati K. G., Bettio M., Spanu T., Leone F., Sechi L. A., Zanetti S., Fadda G., Cauda R.. ( 2001;). Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study. . Clin Infect Dis 33:, 1628–1635. [CrossRef][PubMed]
    [Google Scholar]
  25. Trueba F., Garrabe E., Hadef R., Fabre R., Cavallo J. D., Tsvetkova K., Chesneau O.. ( 2006;). High prevalence of teicoplanin resistance among Staphylococcus epidermidis strains in a 5-year retrospective study. . J Clin Microbiol 44:, 1922–1923. [CrossRef][PubMed]
    [Google Scholar]
  26. Tschudin Sutter S., Frei R., Dangel M., Gratwohl A., Bonten M., Widmer A. F.. ( 2010;). Not all patients with vancomycin-resistant enterococci need to be isolated. . Clin Infect Dis 51:, 678–683. [CrossRef][PubMed]
    [Google Scholar]
  27. Zong Z. Y., Peng C. H., X. J.. ( 2011;). Diversity of SCCmec elements in methicillin-resistant coagulase-negative staphylococci clinical isolates. . PLoS One 6:, e20191. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.034066-0
Loading
/content/journal/jmm/10.1099/jmm.0.034066-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error